August 6th, 2021 
Daniela Lopez de Luise
-
3rd INTERNATIONAL CONFERENCE ON LYMPHOCYTE ENGINEERING 31 March – 2 April | Munich, Germany 
MEET THE ICLE CO-CHAIRS Interested in learning the latest about cell therapy and its relation to rare, autoimmune, and infectious diseases?
Join Dirk Busch, ICLE Conference Co-Chair; Director at the Institute for Med. Microbiology, Immunology and Hygene Technical University of Munich on Friday 1 April 2022 and learn more about how the orthotopic TCR replacement enables the generation of predictable antigen-specific T cell products.
Dirk Busch is also a Coordinator of the new transregional Collaborative Research Center (CRC) – TRR-338 LETSIMMUN (Lymphocyte Engineering for Therapeutic Synthetic Immunity), based in Munich and Wurzburg.
Join Adi Barzel, ICLE Conference Co-Chair; President of the Israeli Society for Gene and Cell Therapy (ISGCT) on Friday 1 April 2022 and find out more about how in vivo engineered B cells retain memory and secrete high titers of anti-HIV antibodies in mice.
Adi Barzel, is a senior lecturer in the Department of Biochemistry at Tel Aviv University. He is also co-founder of LogicBio Therapeutics Inc and Tabby Therapeutics.
Find out more about our panel of experts and join us in Munich to connect with our speakers in person.
MEET THE EXPERTS 
LEARN TODAY. IMPACT TOMORROW Book your front-row seat for a cornerstone conference on lymphocyte engineering and experience an innovative, multidisciplinary medical event that facilitates the sharing of data, promotes collaborations, and addresses common challenges to advance clinical translation.
Take advantage of the Early Bird discount and save more than €100 on your registration fees. Don’t miss this opportunity for three days of active learning, discussions of real-world case studies, and face-to-face networking with like-minded peers.
Early Bird Registration Deadline: 15 December 2021
Join us as we lead the future in lymphocyte engineering!
REGISTER & SAVE STAY SOCIAL
#ICLE22
Posted in